Insuman Comb 25 Solostar

Insulin human, the active ingredient in Insuman Comb 25 Solostar, is an insulin presented as a premixed insulin injection solution for subcutaneous use. It lowers blood glucose in patients with type 1 and type 2 diabetes mellitus by replacing deficient endogenous insulin.

GNH USA supplies Insuman Comb 25 Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Insuman Comb 25 Solostar is an antidiabetic insulin preparation used to manage blood glucose in diabetes mellitus.

Type 1 diabetes mellitus: provides rapid‑acting and intermediate‑acting insulin to achieve basal‑prandial glucose control. Type 2 diabetes mellitus: supplies combined insulin action to improve overall glycemic control in patients requiring insulin therapy. Diabetes mellitus requiring intensified insulin regimen: offers a convenient premixed formulation to simplify multiple daily injections.

Insuman Comb 25 Solostar may be associated with a range of adverse reactions following subcutaneous administration.

Common Side Effects: - Hypoglycemia: low blood glucose episodes. - Injection site reactions: pain, redness or swelling at the injection site. - Weight gain: increase in body weight during therapy.

Serious or Rare Side Effects: - Severe hypoglycemia: loss of consciousness or seizures. - Allergic reactions: anaphylaxis, urticaria or angioedema. - Lipodystrophy: abnormal fat accumulation or loss at injection sites.

When using Insuman Comb 25 Solostar, several precautions should be observed to ensure safe and effective therapy.

Dose adjustment: modify dose based on blood glucose monitoring and clinical response. Renal impairment: monitor closely as insulin clearance may be reduced. Hepatic dysfunction: assess glucose control regularly. Concurrent illness: increase monitoring during infection or stress. Pregnancy and lactation: use only if benefits outweigh risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 25 Solostar can interact with other medicines, altering its glucose‑lowering effect or increasing risk of adverse events.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms. - MAO inhibitors: can potentiate insulin effect. - Systemic corticosteroids: may cause hyperglycemia requiring dose increase.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose. - Oral antidiabetic agents (e.g., sulfonylureas): additive hypoglycemia risk. - ACE inhibitors: may enhance insulin sensitivity.